Elena S. Kravtsova

Elena S. Kravtsova

Auto-generated profile, based on publicly available information

Elena S. Kravtsova

Федеральное государственное бюджетное образовательное учреждение высшего образования «Алтайский государственный медицинский университет», Алтайский край, г. Барнаул, Российская Федерация

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Pediatric and Adolescent Reproductive Health
Verified
Journal Article
Open access
OBO.V. Bulanina
O.V. Bulanina
IKI.V. Kravtsov
I.V. Kravtsov
EKE.S. Kravtsova
E.S. Kravtsova
KDK.V. Dmitrienko
K.V. Dmitrienko
Аспекты гинекологической заболеваемости и контрацептивного поведения учащихся средних специальных и общеобразовательных учебных заведений

21 July 2023 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
TCT. M. Cherkasova
T. M. Cherkasova
AKA. B. Kazanina
A. B. Kazanina
NGN. L. Gurevich
N. L. Gurevich
EKE. S. Kravtsova
E. S. Kravtsova
VMV. M. Moskvina
V. M. Moskvina
In the modern world, the problem of simultaneous infection with syphilis and HIV infection is of particular relevance. The same conditions and transmission routes, identical contingents at risk of infection, make it possible to assume the presence of coinfection with a high degree of probability. It should be noted that in an HIV-infected pregnant woman, against the background of receiving antiretroviral therapy, the clinical picture of syphilis changes, its diagnosis becomes difficult, and the risk of infection of the newborn increases.

1 January 2026 in Bulletin of Medical Science
Verified
Journal Article
Closed access
TCTatiana M. Cherkasova
Tatiana M. Cherkasova
AKAnastasia B. Kazanina
Anastasia B. Kazanina
EKElena S. Kravtsova
Elena S. Kravtsova
SDSvetlana N. Duplik
Svetlana N. Duplik
NANatalya A. Akulova
Natalya A. Akulova
Hemolytic disease of the newborn (HDN) resulting fr om Rh-isoimmunization continues to be a significant contributor to severe neonatal morbidity. Traditionally, elevated levels of maternal antibodies (≥ 1:128) are linked to the onset of early and severe hyperbilirubinemia. Nevertheless, clinical practice reveals instances that challenge the direct relationship between laboratory findings and clinical manifestations, leading to diagnostic challenges and necessitating tailored management strategies. This phenomenon illustrates a rare atypical variant of the progression of GBN due to dual sensitization (D and C antigens), wh ere critically elevated antibody titers resulted in life-threatening, refractory anemia. Objective. This study aims to analyze a clinical case of severe hemolytic disease of the newborn attributed to incompatibility with two antigens (Rh(D) and Rh(C)), with the goal of identifying the characteristics of the disease's progression, diagnosis, and management strategies. Materials and Methods. An analysis was conducted on medical documentation, which included the developmental history of newborns, the exchange card of the pregnant woman, the woman in labor, and the postpartum woman. Additionally, daily clinical and neurological assessments were reviewed, alongside the evaluation of hemogram indicators, biochemical blood tests, and instrumental examination methods such as neurosonography and Doppler ultrasonography. Results. This report presents a clinical case of hemolytic disease in a newborn, attributed to dual sensitization to D and C antigens, with a notable emphasis on bone marrow suppression rather than hemolysis. Conclusion. The clinical observation illustrates the intricate and multifactorial aspects of the pathogenesis of neonatal hemolytic disease, which extends beyond conventional classification frameworks. The findings compellingly underscore the necessity for a personalized assessment of a comprehensive array of clinical and laboratory parameters (including antibody titer, anemia dynamics, bilirubin levels, reticulocyte counts, and the overall condition of the patient) to determine the most effective management approach. The distinctive characteristics of this case, which is infrequently e

1 January 2025 in Bulletin of Medical Science
Verified
Journal Article
Closed access
TCTatiana M. Cherkasova
Tatiana M. Cherkasova
AKAnastasia B. Kazanina
Anastasia B. Kazanina
EKElena S. Kravtsova
Elena S. Kravtsova
APAltai Regional Clinical Center For Maternity And Childhood Protection
Altai Regional Clinical Center For Maternity And Childhood Protection
OMOlga N. Malchenko
Olga N. Malchenko
OSOlga P. Shmeleva
Olga P. Shmeleva
Objective. Present the characteristics of the clinical course of hemophilia A in a newborn, the stages of diagnosis, and treatment. Materials and Methods. A retrospective analysis of medical documentation was carried out: the exchange card of the pregnant woman, the woman in labor, and the woman in labor (form No. 113/u-20); the individual medical card of the pregnant woman and the woman in labor (form No. 111/u-20); the history of the newborn's development (form No. 097/u). Results. A clinical case of hemophilia A in a newborn child is presented in the form of cutaneous hemorrhagic syndrome, with hematomic type of bleeding on the first day of life. Conclusion. Severe hemophilia A (hereditary factor VIII deficiency) is a rare disease that manifests itself in the neonatal period. The cause of the disease in this newborn is not related to a hereditary family history, but rather a high probability of spontaneous mutation of a large gene for blood coagulation factor VIII. The timely diagnosis is important, the key method of which is to evaluate the indicators of coagulological examination, determine the activity of the factor, and ensure its correction in optimal time to reduce mortality and improve quality of life.

30 April 2026 in Наука и здравоохранение
Verified
Journal Article
Open access
PDF file
ТЧТатьяна Черкасова
Татьяна Черкасова
АКАнастасия Казанина
Анастасия Казанина
ЕКЕлена Кравцова
Елена Кравцова
НАНазым Аильбаева
Назым Аильбаева
НФНаталья Феер
Наталья Феер
ААА.р. Алимбаева
А.р. Алимбаева
Актуальность: Тромбоцитопения, определяемая как снижение уровня тромбоцитов ниже 150 ×10⁹/л, является одним из наиболее частых гематологических нарушений в неонатологии, встречаясь у 1–5% всех новорожденных. Данное состояние представляет собой значимую клиническую проблему, так как ассоциировано с повышенным риском геморрагических осложнений [4]. Цель исследования. Изучить распространенность, факторы риска (причины) и клинические проявления в зависимости от степени тяжести тромбоцитопении у новорожденных. Материалы и методы. Проведено ретроспективное моноцентровое когортное исследование на базе КГБУЗ «Алтайский краевой клинический перинатальный центр «Дар» (г. Барнаул). Исследование охватывает период с 1 января по 31 декабря 2024 года. Проанализирована медицинская документация: истории развития новорожденных (форма № 097/у; обменные карты беременных, рожениц и родильниц (формы № 111/у-20 и № 113/у-20). Анализ ежедневных клинических и неврологических осмотров, изучены показатели гемограмм, биохимических исследований крови, коагулограмм, электролитного обмена (калий, натрий, кальций и хлор сыворотки), инструментальных методов исследования (нейросонография (НСГ) и допплерография). Заключение.Распространенность неонатальной тромбоцитопении в условиях крупного перинатального центра составляет 2,5%, при этом большинство случаев (78,6%) протекает в легкой, зачастую бессимптомной форме. Хроническая фетоплацентарная недостаточность у матери и, в особенности, задержка роста плода являются наиболее значимыми независимыми факторами риска развития среднетяжелых и тяжелых форм тромбоцитопении, повышая риск в 6,8 и 17,3 раза соответственно. Клиническая манифестация геморрагического синдрома достоверно коррелирует со степенью снижения уровня тромбоцитов (< 100 × 10⁹/л), а его патогенез связан как с количественным дефицитом, так и с функциональной неполноценностью тромбоцитов. Relevance:Thrombocytopenia, defined as a decrease in the platelet count below 150 ×10⁹/l, is one of the most common hematological disorders in neonatology, occurring in 1–5% of all newborns. This condition represents a significant clinical problem, as it is associated with an increased risk of hemorrhagic complications. Aim. To study the prevalence, risk factors (causes), and clinical manifestations depending on the severity of thrombocytopenia in newborns. Materials and methods. A retrospective monocenter cohort study was conducted on the basis of the Altai Regional Clinical Perinatal Center "Dar" (Barnaul). The study covers the period from January 1 to December 31, 2024. The medical documentation was analyzed: the history of the development of newborns (form No. 097/u; exchange cards of pregnant women, women in labor and women in labor (forms No. 111/u-20 and No. 113/u-20). Analysis of daily clinical and neurological examinations, studied indicators of hemograms, biochemical studies of blood, coagulograms, electrolyte exchange (potassium, sodium, calcium and chlorine of serum), instrumental methods of research (neurosonography (NSG) and Dopplerography). Conclusion. The prevalence of neonatal thrombocytopenia in the conditions of a large perinatal center is 2.5%, while most cases (78.6%) occur in a mild, often asymptomatic form. Chronic fetoplacental insufficiency in the mother and, especially, fetal growth restriction are the most significant independent risk factors for the development of moderate and severe forms of thrombocytopenia, increasing the risk by 6.8 and 17.3 times, respectively. The clinical manifestation of hemorrhagic syndrome correlates significantly with the degree of platelet count reduction (< 100 × 10⁹/L), and its pathogenesis is associated with both quantitative deficiency and functional insufficiency of platelets. Кіріспе. Тромбоцитопения – тромбоциттер деңгейінің 150 ×10⁹/л-ден төмендеуімен сипатталатын жағдай. Ол неонатологияда жиі кездесетін гематологиялық бұзылыстардың бірі болып табылады және барлық жаңа туған нәрестелердің 1–5%-ында анықталады. Бұл жағдай клиникалық тұрғыдан маңызды мәселе болып саналады, себебі ол геморрагиялық асқынулар қаупінің...

1 January 2024 in Bulletin of Medical Science
Verified
Journal Article
Open access
TCTatyana M. Cherkasova
Tatyana M. Cherkasova
AUAltai State Medical University
Altai State Medical University
DADaria E. Andreeva
Daria E. Andreeva
AKAnastasia B. Kazanina
Anastasia B. Kazanina
EKElena S. Kravtsova
Elena S. Kravtsova
IKIrina V. Kurdeko
Irina V. Kurdeko
The article presents a distinctive clinical scenario involving a newborn with a dual cardiovascular system anomaly: Ebstein's anomaly and aortic coarctation. Challenges in diagnosing this condition stem from the unique clinical presentation of the disease and the functionality of fetal pathways during the initial neonatal phase. The authors emphasize the criticality of promptly diagnosing congenital heart defects, primarily through echocardiography, and efficiently correcting them within an optimal timeframe to diminish mortality rates and enhance the quality of life.